期刊文献+

糜酶抑制剂在体外对肝星状细胞增殖及肝纤维化相关基因表达的影响 被引量:1

Effects of chymase inhibitor on the proliferation of hepatic stellate cells and the expression of hepatic fibrosis-related genes in vitro
在线阅读 下载PDF
导出
摘要 [目的]探讨糜酶抑制剂(Chy-I)在体外对肝星状细胞(HSC)增殖及肝纤维化相关基因表达的影响及作用机制.[方法]取HSC-T6细胞,分为对照组(DMEM)、模型组(TGF-β1)和Chy-I大、中、小剂量(TGF-β1+100 g/L Chy-I,TGF-β1+10 g/L Chy-I,TGF-β1+1 g/L Chy-I)组,检测Chy-I对HSC-T6细胞的增殖抑制率,采用Western blot法检测纤维化相关因子α-SMA及TGF-β1蛋白表达水平,应用实时定量PCR法检测α-SMA及I型胶原mRNA的表达情况.[结果]与模型组比较,Chy-I各剂量组HSC-T6细胞增殖明显受到抑制(P<0.05,P<0.01),且呈剂量依赖性;Western blot法检测结果显示,与模型组比较,Chy-I各剂量组HSC-T6细胞中α-SMA及TGF-β1蛋白表达明显受到抑制,亦呈剂量依赖性,Chy-I各组HSC-T6细胞内α-SMA及I型胶原mRNA表达水平明显降低.[结论]Chy-I在体外对HSC发挥抗肝纤维化作用,其机制认为可能与抑制HSC增殖水平及肝纤维化相关因子的表达有关系. OBJECTIVETo investigate the effects of chymase inhibitor(Chy-I)on the proliferation of hepatic stellate cells(HSC)and the expression of hepatic fibrosis-related genes in vitro and its mechanism.METHODS HSC-T6cells were cultured and divided into control group(DMEM),model group(TGF-β1)and Chy-I high,medium and low dose groups(TGF-β1+100g/L Chy-I,TGF-β1+10g/L Chy-I,TGF-β1+1g/L Chy-I).The proliferation inhibition rate of Chy-I on HSC-T6 cells was detected.Western blot was used to detect the protein expression levels of fibrosis-related factorsα-SMA and TGF-β1.Real-time PCR was used to detect the mRNA expressions ofα-SMA and collagen I.RESULTS Compared with model group,the proliferations of HSC-T6cells in all Chy-I groups were significantly inhibited(P<0.05,P<0.01),and in a dose-dependent manner.The results of Western blot showed that the protein levels ofα-SMA and TGF-β1 of HSC-T6 cells in each Chy-I group were significantly inhibited as compared with the model group,and it was also in a dose-dependent manner.The mRNA expressions ofα-SMA and collagen I of HSC-T6 cells in each Chy-I group were significantly decreased.CONCLUSION Chy-I played the role of anti-hepatic fibrosis on HSC in vitro,and its mechanism might be related to the inhibition of HSC proliferation and the expression of hepatic fibrosis-related factors.
作者 金善姬 尹明实 JIN Shanji;YIN Mingshi(Affiliated Hospital of Yanbian University,Yanji 133000,Jilin,China)
出处 《延边大学医学学报》 CAS 2019年第3期159-162,共4页 Journal of Medical Science Yanbian University
基金 国家自然科学基金项目(81760113)
关键词 肝星状细胞 糜酶抑制剂 Α-SMA TGF-Β1 胶原 hepatic stellate cells chymase inhibitor α-SMA TGF-β1 collagen
  • 相关文献

参考文献2

二级参考文献22

  • 1Colette C Prosser,Roy D Yen,Jan Wu.Molecular therapy for hepatic injury and fibrosis:Where are we?[J].World Journal of Gastroenterology,2006,12(4):509-515. 被引量:41
  • 2CHENG Yang PING Jian XU Lie-ming.Effects of curcumin on peroxisome proliferator-activated receptor γ expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells[J].Chinese Medical Journal,2007(9):794-801. 被引量:34
  • 3Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesisj L] . Hepatology, 2010, 52 (5): 1836-1846.
  • 4Neuschwander- Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis , the central role of nontriglyceride fatty acid metabolites [J]. Hepatology, 2010,52 (2): 774-788.
  • 5Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression [J]. Cell, 2010, 140 (2): 197-208.
  • 6Yamaguchi K, Itoh Y, Y okomizo C, et al. Blockade of IL- 6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline?deficient diet-fed db/db mice [J]. Lab Invest, 2011, 91 (4) : 609-618.
  • 7Kroy DC, Beraza N, Tschaharganeh DF, et al. Lack of interleukin -6/ glycoprotein 130/ signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice [J] . Hepatology, 2010, 51 (2): 463-473.
  • 8Miller AM, Wang H, Bertola A, et al. Inflammation?associated interleukin-6/ signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-lO-deficient mice] 1]. Hepatology, 2011, 54 (3) : 846-856.
  • 9Harley IT, Stankiewicz TE, Giles DA, et al. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice [J]. Hepatology, 2014, 59 (5): 1830-1839.
  • 10Tang Y, Bian Z, Zhao L, et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease [J]. Clin Exp Immunol, 2011, 166 (2): 281-290.

共引文献7

同被引文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部